Discovery of MK-1439, an orally bioavailable non-nucleoside reverse transcriptase inhibitor potent against a wide range of resistant mutant HIV viruses von Côté, Bernard, Burch, Jason D., Asante-Appiah, Ernest, Bayly, Chris, Bédard, Leanne, Blouin, Marc, Campeau, Louis-Charles, Cauchon, Elizabeth, Chan, Manuel, Chefson, Amandine, Coulombe, Nathalie, Cromlish, Wanda, Debnath, Smita, Deschênes, Denis, Dupont-Gaudet, Kristina, Falgueyret, Jean-Pierre, Forget, Robert, Gagné, Sébastien, Gauvreau, Danny, Girardin, Melina, Guiral, Sébastien, Langlois, Eric, Li, Chun Sing, Nguyen, Natalie, Papp, Rob, Plamondon, Serge, Roy, Amélie, Roy, Stéphanie, Seliniotakis, Ria, St-Onge, Miguel, Ouellet, Stéphane, Tawa, Paul, Truchon, Jean-François, Vacca, Joe, Wrona, Marc, Yan, Youwei, Ducharme, Yves

Volltext

Discovery of Potent and Orally Bioavailable Pyrimidine Amide cGAS Inhibitors via Structure-Guided Hybridization von Cyr, Patrick, Fader, Lee D., Burch, Jason D., Pike, Kelly A., Sietsema, Daniel V., Boily, Marc-Olivier, Ciblat, Stéphane, Sgarioto, Nicolas, Skeldon, Alexander M., Gaudreault, Samuel, Le Gros, Philippe, Dumais, Valérie, McKay, Daniel J. J., Abraham, Nathan S., Seliniotakis, Ria, Beveridge, Ramsay E.

Volltext